Skip to main content
. 2021 Dec 27;25:101687. doi: 10.1016/j.pmedr.2021.101687

Table 2.

Quality assessment using the AMSTAR-2.

Cairns et al., 2014 Collins et al., 2019 Eime et al., 2013 Evans et al., 2017 Panza et al., 2020 Zuckerman et al., 2020
Item 1 PICO components No Yes No Yes No Yes
Item 2a A priori protocol No No No No Partial yes No
Item 3 Study design Yes No No No Yes No
Item 4a Search strategy Partial yes Partial yes Partial yes Partial yes Partial yes No
Item 5 Study selection No Yes No No Yes Yes
Item 6 Data extraction Yes No No Yes Yes Yes
Item 7a Excluded studies No No No Yes No No
Item 8 Description of included studies No No Partial yes Partial yes Yes No
Item 9a RoB assessment No Partial yes Partial yes No No Yes
Item 10 Reported funding No No No No No No
Item 11a Meta-analyses methods Yes No NAb NAb Yes Yes
Item 12 Assess impact RoB on results meta-analysis No Yes NAb NAb No Yes
Item 13a Account for RoB in interpreting/discussing of results No Yes Yes Yes No No
Item 14 Explanation of heterogeneity No Yes Yes Yes Yes Yes
Item 15a Publication bias Yes Yes NAb NAb Yes No
Item 16 Conflict of interest Yes Yes Yes Yes No Yes
Overall score Quality of the review Critically low quality review Critically low quality review Moderate quality review Critically low quality review Critically low quality review Critically low quality of review

aIndicates a critical item on the AMSTAR-2; also shown in bold; bNA indicates not applicable i.e. no meta-analysis conducted.

Rating was as follows: high quality of review: No or one non-critical weakness, Moderate quality of review: More than one non-critical weakness, Low quality of review: One critical flaw with or without non-critical weaknesses, Critically low quality of review: More than one critical flaw with our without non-critical weaknesses.

PICO = population, intervention/exposure, control/comparator, outcome; RoB = Risk of Bias.